NCT02669901View on ClinicalTrials.gov

Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder

NACompletedINTERVENTIONAL

Enrollment

395

Participants

Timeline

Start Date

April 4, 2016

Primary Completion Date

May 16, 2017

Study Completion Date

August 20, 2020

Conditions

Opiate Antagonist OverdoseOpioid-Related Disorders

Interventions

BEHAVIORAL

Naloxone Auto-Injector

Naloxone auto-injector is FDA approved and labeled for use by family members or caregivers for emergency therapy and rescue wherever opioids are present. Bystanders of patient are able to provide naloxone when drug overdose occurs.

Trial Locations (1)

87106

UNM Hospitals - Alcohol and Substance Abuse Program, Albuquerque

All Listed Sponsors

collaborator

Kaleo Inc.

OTHER

lead

University of New Mexico

OTHER

NCT02669901 - Naloxone Auto-injector as a Universal Precaution for Patients With Opioid Use Disorder | Biotech Hunter | Biotech Hunter